CoChat
Cited by 218

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cells

Open access
Pennisi, Martina, Sanchez-Escamilla, Miriam, Flynn, Jessica R., Shouval, Roni, Alarcon Tomas, Ana, Silverberg, Mari Lynn, Batlevi, Connie, Brentjens, Renier J., Dahi, Parastoo B., Devlin, Sean M., Diamonte, Claudia, Giralt, Sergio, Halton, Elizabeth F., Jain, Tania, Maloy, Molly, Mead, Elena, Palomba, Maria Lia, Ruiz, Josel, Santomasso, Bianca, Sauter, Craig S., Scordo, Michael, Shah, Gunjan L., Park, Jae H., Yanez San Segundo, Lucrecia, Perales, Miguel-Angel · 2021 · Blood Advances

Abstract

Patients who develop chimeric antigen receptor (CAR) T-cell–related severe cytokine release syndrome (CRS) and immune effector cell–associated neurotoxicity syndrome (ICANS) exhibit hemodynamic instability and endothelial activation. The EASIX (Endothelial Activation and Stress Index) score (lactate dehydrogenase [LDH; U/L] × creatinine [mg/dL]/platelets [PLTs; 109 cells/L]) is a marker of endothelial damage that correlates with outcomes in allogeneic hematopoietic cell transplantation. Elevated LDH and low PLTs have been associated with severe CRS and ICANS, as has C-reactive protein (CRP), while increased creatinine is seen only in a minority of advanced severe CRS cases. We hypothesized that EASIX and 2 new modified EASIX formulas (simplified EASIX, which excludes creatinine, and modified EASIX [m-EASIX], which replaces creatinine with CRP [mg/dL]), calculated peri-CAR T-cell infusion, would be associated with development of severe (grade ≥ 3) CRS and ICANS. We included 118 adults, 53 with B-acute lymphoblastic leukemia treated with 1928z CAR T cells (NCT01044069) and 65 with diffuse large B-cell lymphoma treated with axicabtagene ciloleucel or tisagenlecleucel. The 3 formulas showed similar predictive power for severe CRS and ICANS. However, low PLTs and high CRP values were the only variables individually correlated with these toxicities. Moreover, only m-EASIX was a significant predictor of disease response. m-EASIX could discriminate patients who subsequently developed severe CRS preceding the onset of severe symptoms (area under the curve [AUC] at lymphodepletion, 80.4%; at day −1, 73.0%; and at day +1, 75.4%). At day +3, it also had high discriminatory ability for severe ICANS (AUC, 73%). We propose m-EASIX as a clinical tool to potentially guide individualized management of patients at higher risk for severe CAR T-cell–related toxicities.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/bloodadvances.2020003885

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 218

Metadata

Authors
Pennisi, M., Sanchez-Escamilla, M., Flynn, J. R., Shouval, R., Alarcon Tomas, A., Silverberg, M. L., Batlevi, C., Brentjens, R. J., Dahi, P. B., Devlin, S. M., Diamonte, C., Giralt, S., Halton, E. F., Jain, T., Maloy, M., Mead, E., Palomba, M. L., Ruiz, J., Santomasso, B., Sauter, C. S., Scordo, M., Shah, G. L., Park, J. H., Yanez San Segundo, L., & Perales, M.-A.
Venue
Blood Advances
Published
2021-08-25
Volume
5
Issue
17
Pages
3397-3406
ISSN
  • 2473-9529 (ISSN-L)
  • 2473-9537
OpenAlex
W3194859364
Cited by
218
References
11
FWCI
7.75
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cells. https://app.cochat.ai/papers/10.1182/bloodadvances.2020003885
The paper
Pennisi, M., Sanchez-Escamilla, M., Flynn, J. R., Shouval, R., Alarcon Tomas, A., Silverberg, M. L., Batlevi, C., Brentjens, R. J., Dahi, P. B., Devlin, S. M., Diamonte, C., Giralt, S., Halton, E. F., Jain, T., Maloy, M., Mead, E., Palomba, M. L., Ruiz, J., Santomasso, B., . . . Perales, M.-A. (2021). Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cells. Blood Advances. https://doi.org/10.1182/bloodadvances.2020003885

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.